FILING INTELLIGENCE · SOURCE: SEC EDGAR · current OTC reference
TAKEDA PHARMACEUTICAL CO LTD
Business summary
Section 16 Form 4 ownership filing submitted to the SEC.
Filing path
Official disclosure. Monitor subsequent public filings.
Timeline
- Filed: 8/12/2026, 00:00:00
- Capture status: First observed in current verified snapshot
- Source: SEC EDGAR · current OTC reference
Verify all material terms in the official source document.
Open official filing →Issuer profileLive feed